XML 32 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 32,953 $ 33,413 $ 41,381
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 22,890 21,117 19,799
Provision for credit losses 3,351 3,050 2,818
Stock-based compensation expense 6,520 7,703 5,959
Deferred income tax (benefit) expense (698) 3,307 3,036
Amortization of intangibles 1,357 1,401 1,286
Amortization of debt issuance costs 622 699 552
Amortization and accretion of debt 539 515 493
Loss on extinguishment of debt 0 0 190
Net loss on divestitures, disposals and impairment charges 2,580 1,191 2,029
Net gain on property damage, net of insurance claims (417) (343) (3,471)
Gain on sale of excess land 0 (1,407) (155)
Changes in operating assets and liabilities that provided (used) cash:      
Accounts and preneed receivables (24,620) (8,122) (5,358)
Inventories, prepaid and other current assets 1,056 (72) 2,295
Intangible and other non-current assets (4,402) (3,246) (1,917)
Preneed funeral and cemetery trust investments 1,390 (775) (17,679)
Accounts payable 1,616 169 (101)
Accrued and other liabilities 3,590 2,988 (9,120)
Deferred preneed funeral and cemetery revenue 6,866 14,968 1,302
Deferred preneed funeral and cemetery receipts held in trust (3,197) (966) 17,685
Net cash provided by operating activities 51,996 75,590 61,024
Cash flows from investing activities:      
Acquisitions of businesses and real property 0 (44,500) (33,876)
Proceeds from divestitures and sale of other assets 12,057 4,132 5,027
Proceeds from insurance claims 403 1,403 2,440
Capital expenditures (16,098) (18,039) (26,081)
Net cash used in investing activities (3,638) (57,004) (52,490)
Cash flows from financing activities:      
Borrowings from the credit facility 54,900 86,100 155,400
Payments against the credit facility (97,000) (97,700) (120,100)
Payment of debt issuance costs for the credit facility (781) 0 (922)
Payments on acquisition debt and obligations under finance leases (1,061) (1,167) (882)
Proceeds from the exercise of stock options and employee stock purchase plan contributions 2,626 1,494 1,745
Taxes paid on restricted stock vesting and exercise of stock options (593) (252) (327)
Dividends paid on common stock (6,807) (6,708) (6,763)
Purchase of treasury stock 0 0 (36,663)
Net cash used in financing activities (48,716) (18,233) (8,512)
Net (decrease) increase in cash and cash equivalents during the year (358) 353 22
Cash and cash equivalents at beginning of year 1,523 1,170 1,148
Cash and cash equivalents at end of year $ 1,165 $ 1,523 $ 1,170